secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enovis CORP (ENOV)
CIK:        0001420800
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001193125-24-000976
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 2.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enovis Corp closes acquisition of LimaCorporate for ~€727M cash plus 1.94M shares
--------------------------------------------------------------------------------

- Completed acquisition of LimaCorporate on Jan 3, 2024 for ~€726.8M cash plus 1,942,686 shares valued at €100M.
- Acquisition financed with term loan facility and proceeds from 3.875% convertible senior notes due 2028.
- Lima adds 3D-printed Trabecular Titanium implants and comprehensive shoulder revision portfolio.
- Enovis' recon segment to reach $1B in revenue, accelerating global growth and margin expansion.
- CEO Matt Trerotola highlights strategic acquisition to drive compounding value for shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420800/000119312524000976/0001193125-24-000976-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420800/000119312524000976/d697122d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-000976

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer